UNSPSC 51391800: Sympathomimetic or adrenergic amphetamines

Sympathomimetic or adrenergic drugs made from a powerful central nervous system stimulant and Phenethylamine.

UNSPSC 51391800 Sympathomimetic or adrenergic amphetamines is a Class code that in recent state and local solicitations does not align with its nominal pharmaceutical scope. The posted opportunities show a mismatch: Seminole County, Florida's IFB for naloxone and drug deactivation systems targets opioid-overdose response and harm reduction, while the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescriptions addresses pharmacy benefit program structure and cost management without reference to sympathomimetic agents. Neither solicitation reflects procurement of adrenergic amphetamines as a product category. The code shows limited and off-scope recent activity in state and local contracting.

The two posted opportunities span different geographies and issuing-body types with no overlap. Seminole County's IFB (posted June 30, 2026, due July 26, 2023) seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with quarterly deliveries to the county community health building in Sanford, Florida; the contract includes a two-year initial term with optional one-year renewal and covers standard compliance requirements including E-Verify and drug-free workplace certification. Texas HHS's RFI (posted April 3, 2026, response due April 3, 2026) is a preliminary market-intelligence solicitation exploring vendor capacity for direct-to-manufacturer prescription contracts outside traditional pharmacy benefit manager and wholesaler channels, with no award values, set-asides, or formal evaluation criteria specified at the RFI stage. The geographic spread reflects Florida and Texas activity, but the code's nominal pharmaceutical classification does not meaningfully frame either procurement.